| Unique ID issued by UMIN | UMIN000054359 |
|---|---|
| Receipt number | R000061833 |
| Scientific Title | A Cross-Sectional Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin |
| Date of disclosure of the study information | 2024/05/10 |
| Last modified on | 2025/05/11 09:10:14 |
A Cross-Sectional Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin
A Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin
A Cross-Sectional Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin
A Study on the Serum Metal Levels in Patients with Type 2 Diabetes Treated with Metformin
| Japan |
Type 2 diaebtes
| Endocrinology and Metabolism |
Others
NO
Measuring metal-related parameters in patients with and without metformin treatment to elucidate the changes in metal dynamics in patients with type 2 diabetes taking metformin.
Safety
Exploratory
Not applicable
Comparing serum copper levels in patients with type 2 diabetes with and without metformin.
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
Metformin Treatment Group:
1. Diagnosed with type 2 diabetes at the time of registration.
2. Aged 18 years or older.
3. Has been continuously taking metformin for at least six months at the time of registration.
4. Has provided written informed consent for participation in this study.
Control Group: Non-Metformin Users:
1. Diagnosed with type 2 diabetes at the time of registration.
2. Aged 18 years or older.
3. Has not been taking metformin continuously for at least six months at the time of registration.
4. Has provided written informed consent for participation in this study.
1. Patients currently taking iron supplements.
2. Patients currently taking zinc supplements.
3. Patients currently taking vitamin B12 supplements.
4. Patients currently taking folic acid supplements.
5. Patients with anemia.
6. Patients who have undergone gastric, duodenal, or small intestine resection (excluding those who have undergone endoscopic mucosal resection or submucosal dissection).
7. Patients who are pregnant or breastfeeding.
8. Patients with malabsorption issues (e.g., chronic pancreatitis, inflammatory bowel disease, malabsorption syndrome).
9. Patients with renal dysfunction (eGFR < 30 mL/min/1.73m2).
10. Patients with cirrhosis.
11. Patients currently undergoing treatment for malignant tumors.
12. Other patients deemed inappropriate for the study by the investigator.
200
| 1st name | Kazuhiko |
| Middle name | |
| Last name | Sakaguchi |
Kobe University Graduate School of Medicine
Division of Diabetes and Endocrinology
650-0017
7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan
078-382-5861
kzhkskgc@med.kobe-u.ac.jp
| 1st name | Natsu |
| Middle name | |
| Last name | Otowa-Suematsu |
Kobe University Graduate School of Medicine
Division of Diabetes and Endocrinology
650-0017
7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan
078-382-5861
suematsu@med.kobe-u.ac.jp
Kobe University
Manpei Suzuki Diabetes Foundation
Non profit foundation
Kobe University Hospital Clinical and Translational Research Center
7-5-2 Kusunokichou, Chuo-ku, Kobe, Japan
078-382-6669
kansatsu@med.kobe-u.ac.jp
NO
| 2024 | Year | 05 | Month | 10 | Day |
Unpublished
199
Completed
| 2022 | Year | 06 | Month | 01 | Day |
| 2022 | Year | 07 | Month | 20 | Day |
| 2022 | Year | 07 | Month | 20 | Day |
| 2025 | Year | 03 | Month | 31 | Day |
Cross-sectional observational study
| 2024 | Year | 05 | Month | 10 | Day |
| 2025 | Year | 05 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061833